Technology Transfer. 2.1 MPP will cause the Technology Transfer to be conducted in accordance with the chronogram as described in Annex 1. Prior to Technology Transfer activities taking place, the Spoke will receive an introduction to the mRNA technology training provided by Afrigen. WHO will engage with the Spoke to discuss requirements for investments and workforce development to enable readiness at the Spoke Facilities to receive the Technology Transfer. In addition, WHO will facilitate access to dedicated biomanufacturing trainings (manufacturing/good manufacturing practice base training) and appropriate tools to allow informed decisions to be taken by Spoke. The Technology Transfer will be offered as sequential packages described in Annex 3:
Appears in 4 contracts
Samples: Vaccine Technology Transfer Agreement, Vaccine Technology Transfer Agreement, Vaccine Technology Transfer Agreement
Technology Transfer. 2.1 MPP will cause the Technology Transfer to be conducted in accordance with the chronogram as described in Annex 1. Prior to Technology Transfer activities taking place, the Spoke IPT will receive an introduction to the mRNA technology training provided by Afrigen. WHO will engage with the Spoke IPT to discuss requirements for investments and workforce development to enable readiness at the Spoke IPT Facilities to receive the Technology Transfer. In addition, WHO will facilitate access to dedicated biomanufacturing trainings (manufacturing/good manufacturing practice base training) and appropriate tools to allow informed decisions to be taken by SpokeIPT. The Technology Transfer will be offered as sequential packages described in Annex 3:
Appears in 1 contract
Technology Transfer. 2.1 MPP will cause the Technology Transfer to be conducted in accordance with the chronogram as described in Annex 1. Prior to Technology Transfer activities taking place, the Spoke [XXX] will receive an introduction to the mRNA technology training provided by Afrigen. WHO will engage with the Spoke [XXX] to discuss requirements for investments and workforce development to enable readiness at the Spoke [XXX] Facilities to receive the Technology Transfer. In addition, WHO will facilitate access to dedicated biomanufacturing trainings (manufacturing/good manufacturing practice base training) and appropriate tools to allow informed decisions to be taken by Spoke[XXX]. The Technology Transfer will be offered as sequential packages described in Annex 3:
Appears in 1 contract
Technology Transfer. 2.1 MPP will cause the Technology Transfer to be conducted in accordance with the chronogram as described in Annex 1. Prior to Technology Transfer activities taking place, the Spoke IPD will receive an introduction to the mRNA technology training provided by Afrigen. WHO will engage with the Spoke IPD to discuss requirements for investments and workforce development to enable readiness at the Spoke IPD Facilities to receive the Technology Transfer. In addition, WHO will facilitate access to dedicated biomanufacturing trainings (manufacturing/good manufacturing practice base training) and appropriate tools to allow informed decisions to be taken by SpokeIPD. The Technology Transfer will be offered as sequential packages described in Annex 3:
Appears in 1 contract
Technology Transfer. 2.1 MPP will cause the Technology Transfer to be conducted in accordance with the chronogram as described in Annex 1. Prior to Technology Transfer activities taking place, the Spoke BVNL will receive an introduction to the mRNA technology training provided by Afrigen. WHO will engage with the Spoke BVNL to discuss requirements for investments and workforce development to enable readiness at the Spoke BVNL Facilities to receive the Technology Transfer. In addition, WHO will facilitate access to dedicated biomanufacturing trainings (manufacturing/good manufacturing practice base training) and appropriate tools to allow informed decisions to be taken by SpokeBVNL. The Technology Transfer will be offered as sequential packages described in Annex 3:
Appears in 1 contract